Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

NARATRIPTAN vs NATALIZUMAB-SZTN: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

NARATRIPTAN vs NATALIZUMAB-SZTN: Safety Overview

Metric NARATRIPTAN NATALIZUMAB-SZTN
Total FAERS Reports 526 188
Deaths Reported 9 2
Death Rate 1.7% 1.1%
Hospitalizations 102 18
Average Patient Age 49.2 yrs 47.0 yrs
% Female Patients 90.0% 84.7%
FDA Approval Date Apr 22, 2011 N/A
Manufacturer Hikma Pharmaceuticals USA Inc. N/A
Route ORAL N/A
Marketing Status Discontinued Prescription